Innovent Biologics (IVBXF) Stock Chart & Stock Price History $13.04 +0.89 (+7.32%) As of 08/8/2025 02:45 PM Eastern Add Compare Share Share Chart Stock AnalysisChartHeadlinesShort InterestBuy This Stock Innovent Biologics Stock Price Performance The Innovent Biologics (IVBXF) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 144.65%, with a year-to-date return of 189.78%. In the past month, the stock has increased 28.09%, reflecting recent market activity. As of the latest close, Innovent Biologics traded at $13.04 with a market cap of and volume of 5,725 shares. Five years ago, the stock traded at $6.60, representing a 97.58% increase over that period. At the time, it had a market cap of and a volume of 74,624 shares. Receive IVBXF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innovent Biologics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+5.25%1 Month Performance+28.09%3 Month PerformanceN/AYear-To-Date Performance+189.78%1 Year Performance+144.65%5 Year Performance+97.58% IVBXF Stock Chart for Sunday, August, 10, 2025 IVBXF Chart by TradingView Innovent Biologics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/08/2025$12.15$13.04+7.32%$13.04$11.805,725 shs$0.0008/07/2025$12.69$12.15-4.25%$13.39$12.0637,324 shs$0.0008/06/2025$12.39$12.69+2.42%$12.80$12.694,472 shs$0.0008/05/2025$12.05$12.39+2.86%$12.39$12.393,531 shs$0.0008/04/2025$12.07$12.05-0.21%$12.05$12.05199 shs$0.0008/01/2025$12.52$12.07-3.59%$12.07$11.8121,587 shs$0.0007/31/2025$12.27$12.52+2.04%$12.61$12.521,733 shs$0.0007/30/2025$12.27$12.27$12.48$12.272,409 shs$0.0007/29/2025$12.07$12.27+1.66%$12.61$12.107,432 shs$0.0007/28/2025$11.50$12.07+4.96%$12.67$11.9110,494 shs$0.00 Get the Latest News and Ratings for IVBXF and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Innovent Biologics and its competitors with MarketBeat's FREE daily newsletter. 07/25/2025$11.50$11.50$12.35$11.50675 shs$0.0007/24/2025$11.50$11.50$12.35$11.50675 shs$0.0007/23/2025$11.90$11.50-3.36%$12.35$11.50675 shs$0.0007/22/2025$12.00$11.90-0.83%$12.00$11.354,100 shs$0.0007/21/2025$11.50$12.00+4.35%$12.09$11.2412,602 shs$0.0007/18/2025$11.47$11.50+0.26%$11.50$11.433,025 shs$0.0007/17/2025$11.47$11.47$11.47$11.471,089 shs$0.0007/16/2025$10.18$11.47+12.67%$11.47$11.471,089 shs$0.0007/15/2025$10.18$10.18$10.18$10.184,284 shs$0.0007/14/2025$10.18$10.18$10.18$10.1810 shs$0.0007/11/2025$10.18$10.18$11.47$10.181,150 shs$0.0007/10/2025$10.64$10.18-4.32%$11.47$10.181,150 shs$0.0007/09/2025$11.00$10.64-3.27%$10.64$10.185,560 shs$0.00 Related Companies ATNFW Stock Chart TRSBF Stock Chart SXTPW Stock Chart ABCZF Stock Chart AGTX Stock Chart AIMAW Stock Chart AGNPF Stock Chart AKBLF Stock Chart DRTSW Stock Chart APLMW Stock Chart Receive IVBXF Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Innovent Biologics and its competitors with MarketBeat's FREE daily newsletter. This page (OTCMKTS:IVBXF) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredGreen Light for These StocksGuess Who Washington Will Partner With Next? The U.S. government just made a bold $400 million move... beco...Stansberry Research | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Innovent Biologics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Innovent Biologics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
